Trial Comparing Capecitabine Plus Oxaliplatin (XELOX) and Capecitabine (X) as First-line Chemotherapy in Elderly Patients With Advanced Gastric Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
The objective of the trial is to compare Overall survival between capecitabine plus oxaliplatin (XELOX) and capecitabine (X) as first-line chemotherapy in elderly patients with advanced gastric cancer.
Epistemonikos ID: 5a93c6dae3a0e0f2a3a4650c43769f1d98a3af30
First added on: May 10, 2024